From August 17, 2023 to March 31, 2024, the company has repurchased 3,040,219 shares, representing 0.63% for CNY 203.98 million. With this, the company has completed the repurchase of 3,040,219 shares, representing 0.63% for CNY 203.98 million under the buyback announced on August 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.78 CNY | -0.18% |
|
+2.70% | -9.19% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.19% | 4.01B | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- 688363 Stock
- News Bloomage BioTechnology Corporation Limited
- Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023.